KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Fulgent Genetics (FLGT) over the last 10 years, with Q3 2025 value amounting to 0.06%.

  • Fulgent Genetics' Return on Capital Employed rose 1200.0% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year increase of 1200.0%. This contributed to the annual value of 0.06% for FY2024, which is 900.0% up from last year.
  • Per Fulgent Genetics' latest filing, its Return on Capital Employed stood at 0.06% for Q3 2025, which was up 1200.0% from 0.06% recorded in Q2 2025.
  • Fulgent Genetics' 5-year Return on Capital Employed high stood at 0.86% for Q1 2021, and its period low was 0.18% during Q3 2024.
  • In the last 5 years, Fulgent Genetics' Return on Capital Employed had a median value of 0.06% in 2023 and averaged 0.17%.
  • As far as peak fluctuations go, Fulgent Genetics' Return on Capital Employed skyrocketed by 8600bps in 2021, and later crashed by -5300bps in 2023.
  • Fulgent Genetics' Return on Capital Employed (Quarter) stood at 0.59% in 2021, then crashed by -77bps to 0.14% in 2022, then crashed by -217bps to 0.16% in 2023, then soared by 60bps to 0.06% in 2024, then increased by 2bps to 0.06% in 2025.
  • Its Return on Capital Employed was 0.06% in Q3 2025, compared to 0.06% in Q2 2025 and 0.06% in Q1 2025.